Streetbeat News

Analyst Ratings

ZBH

Analysts have recently shared mixed ratings on Zimmer Biomet Holdings (NYSE:ZBH), with a notable decrease in the average 12-month price target by 7.29%. The company's financial metrics show strong net margins but challenges in ROE and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

September 05, 2024 | 7:00 pm

VC

Visteon (NASDAQ:VC) has received mixed analyst ratings over the past three months, with a recent average price target of $124, down from $136.10. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Visteon, an automotive electronics supplier, has shown strong financial performance with a 3.15% revenue growth, a 7% net margin, and a 6.57% ROE, surpassing industry averages.

Portfolio Pulse from Benzinga Insights

September 05, 2024 | 7:00 pm

ODFL

Old Dominion Freight Line shares declined after Wells Fargo maintained an Underweight rating and reduced its price target from $175 to $170.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:49 pm

DLTR

Citigroup analyst Paul Lejuez maintains a Neutral rating on Dollar Tree (NASDAQ:DLTR) and lowers the price target from $120 to $64.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:44 pm

MRO

Citigroup analyst Scott Gruber maintains a Neutral rating on Marathon Oil and lowers the price target from $29 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:40 pm

RIGL

HC Wainwright & Co. has reiterated its Buy rating for Rigel Pharmaceuticals, maintaining a price target of $57. This suggests confidence in Rigel's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:38 pm

YEXT

Yext, Inc. (NYSE:YEXT) has been upgraded to Buy by Needham analyst Ryan MacDonald, with a price target of $8. The upgrade follows better-than-expected Q2 EPS results and positive FY25 revenue guidance. The Hearsay acquisition is expected to drive margin expansion despite initial dilution, and cross-sell opportunities could boost growth in FY26.

Portfolio Pulse from Nabaparna Bhattacharya

September 05, 2024 | 6:37 pm

KREF

KKR Real Estate Finance shares rose following an upgrade by Keefe, Bruyette & Woods from Market Perform to Outperform, with a price target increase from $11.5 to $13.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:36 pm

GHRS

HC Wainwright & Co. has reiterated its Buy rating on GH Research (NASDAQ:GHRS) and maintained a price target of $40, indicating confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:36 pm

HES

Citigroup analyst Scott Gruber maintains a Neutral rating on Hess (NYSE:HES) and lowers the price target from $160 to $145.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:36 pm